Document: European Medicines Agency Write PMS API implementation Guide-2025/1/21

Document: European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure-2025/2/24

Document: Scientific advice and protocol assistance adopted during the CHMP meeting 24-27 March 2025-2025/4/1

Recommendations to Reduce the Risk of Transmission of Disease Agents Associated with Sepsis by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) Draft Guidance for Industry-2025/5/2

Document: Superseded opinion of the HMPC on a Community herbal monograph on Zingiber officinale Roscoe, rhizoma-2025/6/19

Document: Guideline on the pharmaceutical quality of inhalation and nasal medicinal products - Revision 1-2025/7/24

Document: Start of procedure: Type II variation - Extension of indication under evaluation by the CHMP (25 July - 21 August 2025)-2025/9/8

Page: European Shortages Monitoring Platform (ESMP)-2025/10/10

国家药监局药审中心关于发布《多联疫苗临床试验技术指导原则》的通告（2025年第48号）-2025/11/18

Document: Work plan for the CVMP Novel Therapies & Technologies Working Party (NTWP) 2026-2025/12/12